Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SRC | P12931 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | HTR6 | P50406 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1095271 | 0.82 | TSHR (0.48) | TSHRSRCALDH1A1HSD17B10TDP1 | |
| SCHEMBL4589500 | 0.80 | SRC (0.54) | TSHRSRCALDH1A1TDP1CYP2C19 | |
| SCHEMBL5200608 | 0.80 | TSHR (0.46) | TSHRSRCALDH1A1HSD17B10TDP1 | |
| SCHEMBL5200599 | 0.80 | TSHR (0.46) | TSHRSRCALDH1A1HSD17B10TDP1 | |
| SCHEMBL4440349 | 0.80 | TSHR (0.46) | TSHRSRCALDH1A1DPP4F2 | |
| SCHEMBL11792813 | 0.77 | TSHR (0.48) | TSHRSRCALDH1A1HSD17B10TDP1 | |
| SCHEMBL31687206 | 0.75 | CA2 (0.39) | CYP2C19F2 | |
| SCHEMBL9449886 | 0.74 | TSHR (0.74) | TSHRSRCALDH1A1HSD17B10TDP1 | |
| SCHEMBL11574577 | 0.73 | CA1 (0.47) | TSHRSRCALDH1A1HSD17B10CYP2C19 | |
| SCHEMBL780336 | 0.72 | CYP2C19 (0.52) | TSHRSRCALDH1A1CYP2C19CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119700791-A | Application of harpagoside in preparation of ionizing radiation injury protection drugs | 中国医学科学院放射医学研究所 | 2025-03-28 | — | — | CN | disclosed |
| CN-119700790-A | Novel therapeutic application of harpagoside | 中国医学科学院放射医学研究所 | 2025-03-28 | — | — | CN | disclosed |
| US-10946075-B1 | Radioprotection, radiomitigation and radiorecovery | RADSYNERGY, LLC | 2021-03-16 | — | — | US | disclosed |
| CN-105623384-A | Ink carriers containing surface modified nanoparticles, phase change inks including same, and methods for making same | XEROX CORP | 2016-06-01 | — | — | CN | disclosed |
| CN-102533002-B | Solid ink containing ketone wax and side chain acid amides | Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) | 2016-01-27 | — | — | CN | disclosed |
| CN-104893408-A | Solid phase change fluorescent ink, ink sets and method for forming image | XEROX CORP | 2015-09-09 | — | — | CN | disclosed |
| CN-101684215-B | Solid phase change fluorescent inks, ink sets and methods of forming images | XEROX CORP. (US) | 2015-08-05 | — | — | CN | disclosed |
| CN-102086322-B | Comprise the solid ink of the polyhydroxyalkanoatefrom compound for strengthening the property | Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) | 2015-07-29 | — | — | CN | disclosed |
| CN-102134201-B | Low molecular weight pigment dispersants for phase change ink | XEROX CORP | 2015-07-08 | — | — | CN | disclosed |
| CN-101891654-B | Low molecular weight quaternary ammonium salt dispersants | XEROX CORP | 2015-04-29 | — | — | CN | disclosed |
| CN-101891654-A | Low molecular weight quaternary ammonium salt dispersants | XEROX CORP | 2010-11-24 | — | — | CN | disclosed |
| CN-101891985-A | The pigmented phase change ink that contains low molecular weight quaternary ammonium salt dispersants | XEROX CORP | 2010-11-24 | — | — | CN | disclosed |
| CN-101805537-A | Ink-jet ink containing nanodiamond black coloring agent | XEROX CORP | 2010-08-18 | — | — | CN | disclosed |
| CN-101735685-A | Phase change inks containing graphene-based carbon allotrope colorants, water-based ink and using method thereof | XEROX CORP | 2010-06-16 | — | — | CN | disclosed |
| CN-101684216-A | Ink carriers containing low viscosity functionalized waxes, phase change inks including same, and methods for making same | XEROX CORP | 2010-03-31 | — | — | CN | disclosed |
| CN-101684215-A | Solid phase change fluorescent inks, ink sets and methods of forming images | XEROX CORP | 2010-03-31 | — | — | CN | disclosed |
| CN-101643603-A | Ink vehicles containing surface-modified nanoparticles and phase change inks including the same | XEROX CORP | 2010-02-10 | — | — | CN | disclosed |
| US-7595347-B2 | Method for protecting normal cells from cytotoxicity of chemotherapeutic agents | Temple University—Of the Commonwealth System of Higher Education (US) | 2009-09-29 | — | — | US | disclosed |
| US-7579587-B2 | Thermally assisted membrane introduction mass spectrometry (MIMS) interface and method of use thereof | VANCOUVER ISLAND UNIVERSITY (CA) | 2009-08-25 | — | — | US | disclosed |
| US-20070181799-A1 | THERMALLY ASSISTED MEMBRANE INTRODUCTION MASS SPECTROMETRY (MIMS) INTERFACE AND METHOD OF USE THEREOF | MALASPINA UNIVERSITY-COLLEGE (CA) | 2007-08-09 | — | — | US | disclosed |